Skip to Main Content
Boston University National Emerging Infectious Diseases Laboratories
Boston University
  • About
  • Faculty
  • Research
  • Safety & Security
  • Community
  • NEIDL in the News
Search
  • Research
    • Research Faculty
    • University Research Partners
    • ​Research News
    • NEIDL Arboviral Research Core (ARC)
  • About
    • Our Mission
    • About the Building
    • The NEIDL Team
  • Safety & Security
    • ​Health & Safety Partners
    • ​Education & Training
    • Potential Exposure Incident Quarterly Reports
    • Safety Plans
  • Community
    • ​Community Liaison Committee
    • ​Resources
  • NEIDL in the News
  • Contact

Featured

TWiV 891: LLOV in the time of Ebola; Interview with Elke Muhlberger & Adam Hume

in Featured, Interviews, Research

Original article from This Week in Virology (TWIV) by Vincent…

Inside the Insectary: How BU Scientists Study Diseases from Mosquitoes—without Getting Bitten

in Featured, In The News, Lab Updates, Research, Video

Original article from The Brink by Devin Hahn & Andrew…

Checking in on the state of the pandemic, 2 years after Mass. emergency declaration

in Featured, In The News, Interviews

Original article from WBUR by Rupa Shenoy & Hafsa Quraishi….

Revealing the hidden value of vaccines (video)

in Featured, In The News, Video

Original article from Nature by Sabin Vaccine Institute. February 16,…

‘Good, not great’: Some long Covid patients see their symptoms improve, but full recovery is elusive

in Featured, In The News

Original article from STAT by Elizabeth Cooney. February 8, 2022…

Research That Matters – NEIDL: Right Place, Right Time

in Featured, In The News, Research

Original article from BU Annual Report. January 31, 2022 Microbiologist…

What causes long Covid? Scientists are zeroing in on the answer.

in Featured, In The News

Original article from Vox By Yasmin Tayag. January 31, 2022…

Here’s what to do after being exposed to omicron

in Featured, In The News

Original article from Boston.com By Gwen Egan. January 24, 2022…

Biden is prioritizing rapid testing to counter omicron. Other countries are far ahead

in Featured, In The News

Original article from The Washington Post By Claire Parker. December…

Merck’s Covid Pill Is Authorized for High-Risk Adults

in Featured, In The News

Original article from The New York Times By Rebecca Robbins…

Posts navigation

← Newer posts
Older posts →

Related to

Translate This Page

Boston University
Boston University National Emerging Infectious Diseases Laboratories
  • X
  • Contact
  • NEIDL Arboviral Research Core (ARC)
© Boston University. All rights reserved. www.bu.edu